Delta sleep-inducing peptide

European Journal of Anaesthesiology

Volumn 18, Issue 7, 2001, Pages 419-422

  Pollard, B J ^a   Pomfrett, C J D ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; CORTICOTROPIN; DELTA SLEEP INDUCING PEPTIDE; PEPTIDE DERIVATIVE; PROSTACYCLIN; RECEPTOR PROTEIN;

ALCOHOL WITHDRAWAL; ANESTHESIA; ANTICONVULSANT ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTINOCICEPTION; BLOOD LEVEL; BREAST MILK; CIRCADIAN RHYTHM; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; EDITORIAL; HUMAN; NEUROPROTECTION; NONHUMAN; SLEEP PATTERN; SLEEP STAGE;

ANESTHESIA; ANTICONVULSANTS; DELTA SLEEP-INDUCING PEPTIDE; HUMANS; SLEEP;

EID: 0035740599     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2346.2001.00917.x     Document Type: Editorial

References (42)

1. Characterization of a delta-electroencephalogram (-sleep)-inducing peptide
2. Delta-sleep-inducing peptide (DSIP): An update
3. Hypnogenic properties of the delta-sleep peptide and its structural analogs
4. Interacting sleep-modulatory effects of simultaneously administered delta-sleep-inducing peptide, muramyl dipeptide and uridine in unrestrained rats
5. The effect of subcutaneous administration of delta sleep-inducing peptide (DSIP) on some parameters of sleep in the cat
6. Modulation of immunoactive levels of DSIP and blood-brain permeability by lighting and diurnal rhythm
7. Diurnal rhythm of plasma delta-sleep-inducing peptide in humans: Evidence for positive correlation with body temperature and negative correlation with rapid eye movement and slow wave sleep
8. Human plasma DSIP decreases at the initiation of sleep at different circadian times
9. Decreased delta-sleep and plasma delta-sleep-inducing peptide in patients with Cushing syndrome
10. Differential penetration of DSIP peptides into rat brain
11. Entry of DSIP peptides into dog CSF role of physicochemical and pharmacokinetic parameters
12. Presence of delta-sleep-inducing peptide-like material in human milk
13. Synthesis of delta sleep-inducing peptide (DSIP) and its physiological activity
14. DSIP occurs in free form in mammalian plasma, human CSF and urine
15. Delta sleep-inducing peptide-like material in rat brain as determined by enzyme immunoassay: Effect of sleep deprivation
16. HPLC shadowing: Artifacts in peptide characterization monitored by RIA
17. Aminopeptidase in human CSF which degrades delta-sleep inducing peptide (DSIP)
18. Study of delta sleep-inducing peptide efficacy in improving sleep on short-term administration to chronic insomniacs
19. DSIP in insomnia
20. Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia
21. Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study
22. Effects of DSIP in man. Multifunctional psychophysiological properties besides induction of natural sleep
23. Delta sleep-inducing peptide in normal humans and in patients with sleep apnea and narcolepsy
24. Effects of DSIP on narcolepsy
25. Effects of delta-sleep-inducing peptide on NMDA-induced convulsive activity in rats
26. Changes in the blastogenic lumphocyte transformation during kindling induced by picrotoxin in rats
27. Circadian effects of beta-endorphin, melatonin, DSIP and amphetamine on pentylenetetrazol-induced seizures
28. The influence of the delta-sleep-inducing peptide on convulsive activity
29. Potent antinociceptive effect of centrally administered delta-sleep-inducing peptide (DSIP)
30. Effects of delta-sleep-inducing peptide in cerebral ischemia in rats
31. The effect of the delta sleep-inducing peptide on the development of toxic brain edema-swelling
32. Delta-sleep-inducing peptide sequels in the mechanisms of resistance to emotional stress
33. Delta-sleep-inducing peptide reduces CRF-induced corticosterone release
34. Different effects of delta-sleep-inducing peptide on arginine-vasopressin and ACTH secretion in normal men
35. Delta-sleep-inducing peptide does not affect CRH and meal-induced ACTH and cortisol secretion
36. Delta sleep-inducing peptide administration does not influence growth hormone and prolactin secretion in normal women
37. Delta-sleep inducing peptide in cerebrospinal fluid from schizophrenics, depressives and healthy volunteers
38. DSIP in the treatment of withdrawal syndromes from alcohol and opiates
39. Delta sleep-inducing peptide in spontaneously hypertensive rats
40. Synthesis and biological properties of delta-sleep peptide analogs. 2. Antimetastatic effect
41. Therapeutic effects of delta-sleep-inducing peptide (DSIP) in patients with chronic, pronounced pain episodes. A clinical pilot study
42. Structure-activity relationship in the effects of delta-sleep-inducing peptide (DSIP) on rat sleep